Vijaya Diagnostic Centre Ltd.

NSE: VIJAYA BSE: 543350 SECTOR: Hospital & Healthcare Services

584.5
-42.5 (-6.78%)
NSE: 20 Sep 04:12 PM

Price Summary

Today's High

₹ 617.8

Today's Low

₹ 575.55

52 Week High

₹ 672

52 Week Low

₹ 532.5

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.

Company Essentials

Market Cap

5959.91 Cr.

Enterprise Value

5771.36 Cr.

No. of Shares

10.2 Cr.

P/E

71.96

P/B

2.64

Face Value

₹ 1

Div. Yield

0%

Book Value (TTM)

₹  221.42

CASH

188.55 Cr.

DEBT

0 Cr.

Promoter Holding

0%

EPS (TTM)

₹  8.12

Sales Growth

11.76%

ROE

25.96 %

ROCE

37.36 %

Profit Growth

35.25 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Ratios

Sales Growth

1 Year11.76%
3 YearNA
5 YearNA

Profit Growth

1 Year35.25%
3 YearNA
5 YearNA

ROE%

1 Year25.96%
3 Year24.6%

ROCE %

1 Year37.36%
3 Year33.88%

Debt/Equity

0

Price to Cash Flow

46.62

Interest Cover Ratio

8.39832436556105

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Share Holding Data is not available for this company.
Report us
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 27.9 Cr.
  • Company has been maintaining healthy ROE of 24.6024099486257% over the past 3 years.
  • Company has been maintaining healthy ROCE of 33.8790756105803% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 8.39832436556105.
  • The company has an efficient Cash Conversion Cycle of -28.0017949926479 days.
  • Company has a healthy liquidity position with current ratio of 6.07073733735969.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 33.1092.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.
Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021
Net Sales 279.08 328.65 367.32
Total Expenditure 187.25 196.2 204.02
Operating Profit 91.83 132.45 163.3
Other Income 8.64 11.79 10.83
Interest 4.36 14.82 14.81
Depreciation 25.69 47.67 49.73
Exceptional Items 0 0 0
Profit Before Tax 70.41 81.75 109.59
Tax 21.49 20.51 26.76
Net Profit 48.92 61.24 82.82
Adjusted EPS (Rs.) 108.01 135.13 18.28

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 6.94 4.53 4.53
Total Reserves 209.04 272.97 356.02
Borrowings 27.9 18.81 0
Other N/C liabilities 7.27 125.41 127.99
Current liabilities 41.14 52.11 38.51
Total Liabilities 292.28 473.83 527.05
Assets
Net Block 136.58 263.93 260.57
Capital WIP 2.71 9.26 8.18
Intangible WIP 0 0.37 1.24
Investments 4.16 4.87 4.87
Loans & Advances 4.57 9.75 9.73
Other N/C Assets 3.09 2.39 8.66
Current Assets 141.18 183.26 233.8
Total Assets 292.28 473.83 527.05
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021
Profit from operations 70.41 81.75 109.59
Adjustment 23.94 50.69 52.55
Changes in Assets & Liabilities 1.01 -0.69 -3.13
Tax Paid -18.81 -23.09 -31.17
Operating Cash Flow 76.56 108.66 127.84
Investing Cash Flow -91.04 -34.31 -128.82
Financing Cash Flow 7.83 -28.08 -48.19
Net Cash Flow -6.65 46.27 -49.17

Corporate Actions

Investors Details

Investors Details is not available for this company. Report us'> Report us

Annual Reports

No Annual reports exist for this company.
Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.
Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.
Report us

Vijaya Diagnostic Stock Price Analysis and Quick Research Report. Is Vijaya Diagnostic an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Vijaya Diagnostic and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 127.8383 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Vijaya Diagnostic has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Vijaya Diagnostic , the EPS growth was -86.4754727456808 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Vijaya Diagnostic has OPM of 44.4568013527321 % which is a good sign for profitability.
     
  • ROE: Vijaya Diagnostic have a healthy ROE of 25.9609645944245 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Vijaya Diagnostic

X